All Knowledge & Insights By Date

In an October 28, 2011, Federal Register notice, the National Cancer Institute’s (NCI) Alliance for Nanotechnology in Cancer announced the initiation of “Translation of Nanotechnology in Cancer” (TONIC), a public private industry partnership intended to promote translational research and development opportunities of nanotechnology-based cancer solutions. The notice states that an immediate consequence of this effort is the formation of a consortium involving government...

Bergeson & Campbell, P.C. (B&C), B&C Consortia Management, L.L.C. (BCCM), The Acta Group, L.L.C. (Acta), and The Acta Group EU, Ltd (Acta EU) are pleased to announce that on October 20, 2011, from 12:00 p.m. to 12:45 p.m. (EDT), Lynn L. Bergeson will speak during the nanoEHS Workshop Series webinar hosted by the National Nanotechnology Initiative (NNI) on the release of its 2011 Environmental, Health, and Safety Research Strategy (Strategy). The event will consist of...

Bergeson & Campbell, P.C. (B&C) is pleased to announce the launch of our newly redesigned website, which has been streamlined to make it easier to navigate. The substantive and timely legal and regulatory information we provide remains available. This information covers a wide range of topics, including the Toxic Substances Control Act (TSCA), nanotechnology, the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), Green Chemistry, the Food and Drug Administration (FDA), the...

On June 9, 2011, the Office of Science and Technology Policy (OSTP) announced that the White House Emerging Technologies Interagency Policy Coordination Committee (ETIPC) has developed a set of principles specific to the regulation and oversight of applications of nanotechnology. The principles are intended to guide the development and implementation of policies, as described in the title "U.S. Decision-making Concerning Regulation and Oversight of Nanotechnology and Nanomaterials" that occur at...

Bergeson & Campbell, P.C. (B&C), B&C Consortia Management, L.L.C. (BCCM), The Acta Group, L.L.C. (Acta), and The Acta Group EU, Ltd (Acta EU) are pleased to announce the addition of Andrew Bourne to its European Union consulting practice. Mr. Bourne's experience in international chemical regulatory programs will supplement the skill sets of other Acta EU professionals and provide even greater service to our growing client base. Mr. Bourne previously worked for Exponent International...

The President’s Council of Advisors on Science and Technology (PCAST) seeks comment from stakeholders on how the federal government can best use its resources so three of the “newest and most promising technologies,” including nanotechnology, “provide the greatest economic benefits to society.” The President’s Innovation and Technology Advisory Committee (PITAC), which is part of PCAST, is soliciting information and ideas from stakeholders — including the research community,...

On January 6, 2010, the U.S. Environmental Protection Agency (EPA) promulgated a final rule amending the electronic reporting requirements under Section 5 of the Toxic Substances Control Act (TSCA) (available online). According to EPA, the amendments are intended to streamline and reduce the administrative costs and burdens of TSCA Section 5 notifications for both industry and EPA by establishing standards and requirements for the use of EPA's Central Data Exchange (CDX) to encrypt and submit...

On March 11, 2008, the German Chemical Industry Association (VCI) released a report entitled Responsible Production and Use of Nanomaterials, which is a series of documents intended to provide guidance on all aspects of a good product stewardship on nanomaterials. The documents include joint papers prepared by VCI and the German Federal Institute for Occupational Safety and Health (BAuA) and the German Society for Chemical Engineering and Biotechnology (DECHEMA). The report...

Many people regard nanotechnology as a "stand-alone" technology. While the technology itself is of great interest, the most intriguing aspect of nanotechnology is that it is increasingly being utilised as an integral part of a more complicated convergence matrix. The intersection of nanotechnology, biotechnology, information technology, and cognitive science, otherwise referred to as ‘NBIC convergence’, is leading to the development of nanobiotechnology products that promise to change...